News briefing: Catalent, Merck KGaA make big investments in manufacturing ops; J&J teams with Datavant on data sharing projects
We’re continuing to see big investments in the global biopharma manufacturing infrastructure.
Wednesday morning Catalent put out the word that it is investing
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.